249 related articles for article (PubMed ID: 18511998)
1. Cure following gene therapy for recurrent glioblastoma multiforme?
Karabatsou K; Bernstein M
Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
[TBL] [Abstract][Full Text] [Related]
2. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results.
Colombo F; Barzon L; Franchin E; Pacenti M; Pinna V; Danieli D; Zanusso M; Palù G
Cancer Gene Ther; 2005 Oct; 12(10):835-48. PubMed ID: 15891772
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy in brain tumours: implications of the size of glioblastoma on its curability.
Izquierdo M; Cortés ML; Martín V; de Felipe P; Izquierdo JM; Pérez-Higueras A; Paz JF; Isla A; Blázquez MG
Acta Neurochir Suppl; 1997; 68():111-7. PubMed ID: 9233425
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for recurrent glioblastoma: pitfalls and future trends.
Franceschi E; Tosoni A; Bartolini S; Mazzocchi V; Fioravanti A; Brandes AA
Expert Rev Anticancer Ther; 2009 May; 9(5):613-9. PubMed ID: 19445578
[TBL] [Abstract][Full Text] [Related]
5. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.
Shand N; Weber F; Mariani L; Bernstein M; Gianella-Borradori A; Long Z; Sorensen AG; Barbier N
Hum Gene Ther; 1999 Sep; 10(14):2325-35. PubMed ID: 10515452
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans.
Palù G; Cavaggioni A; Calvi P; Franchin E; Pizzato M; Boschetto R; Parolin C; Chilosi M; Ferrini S; Zanusso A; Colombo F
Gene Ther; 1999 Mar; 6(3):330-7. PubMed ID: 10435083
[TBL] [Abstract][Full Text] [Related]
7. MRI characteristics and histological changes in glioblastoma after gene therapy.
Weber FW; Floeth FW; Reifenberger G; Felsberg J; Aulich A; Kiwit JC; Bock WJ
Front Radiat Ther Oncol; 1999; 33():244-52. PubMed ID: 10549494
[No Abstract] [Full Text] [Related]
8. [Using the thymidine kinase gene in therapy of solid tumors].
Wicke I; Gansbacher B
Internist (Berl); 1996 Apr; 37(4):369-73. PubMed ID: 8655273
[No Abstract] [Full Text] [Related]
9. Interleukin-2 gene therapy in a patient with glioblastoma.
Sobol RE; Fakhrai H; Shawler D; Gjerset R; Dorigo O; Carson C; Khaleghi T; Koziol J; Shiftan TA; Royston I
Gene Ther; 1995 Mar; 2(2):164-7. PubMed ID: 7719933
[TBL] [Abstract][Full Text] [Related]
10. Gene therapeutics: the future of brain tumor therapy?
Cutter JL; Kurozumi K; Chiocca EA; Kaur B
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1053-64. PubMed ID: 16831077
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma multiforme: evidence-based approach to therapy.
Nicholas MK
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
[TBL] [Abstract][Full Text] [Related]
12. Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: case report.
Ito M; Wakabayashi T; Natsume A; Hatano H; Fujii M; Yoshida J
Neurosurgery; 2007 Jul; 61(1):E168-9; discussion E169. PubMed ID: 17621007
[TBL] [Abstract][Full Text] [Related]
13. Potential confounding features in p53 gene therapy of recurrent glioma.
Weil RJ
J Clin Oncol; 2004 Apr; 22(7):1344-5; author reply 1345. PubMed ID: 15051789
[No Abstract] [Full Text] [Related]
14. Survival outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy.
Blumenthal DT; Schulman SF
Expert Rev Neurother; 2005 Sep; 5(5):683-90. PubMed ID: 16162092
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of glioblastoma recurrences].
Schratter-Sehn AU; Marosi C
Wien Med Wochenschr; 2011 Jan; 161(1-2):1-2. PubMed ID: 21312091
[No Abstract] [Full Text] [Related]
16. Novartis licenses gene therapy to avoid monopoly.
Glaser V
Nat Biotechnol; 1997 Feb; 15(2):118-9. PubMed ID: 9035126
[No Abstract] [Full Text] [Related]
17. [Gene therapy for brain tumors].
Mizuno M; Yoshida J
Nihon Rinsho; 1997 Jul; 55(7):1853-60. PubMed ID: 9233039
[TBL] [Abstract][Full Text] [Related]
18. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.
Prados MD; McDermott M; Chang SM; Wilson CB; Fick J; Culver KW; Van Gilder J; Keles GE; Spence A; Berger M
J Neurooncol; 2003 Dec; 65(3):269-78. PubMed ID: 14682377
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for malignant glioma.
Lesniak MS
Expert Rev Neurother; 2006 Apr; 6(4):479-88. PubMed ID: 16623647
[TBL] [Abstract][Full Text] [Related]
20. Local immunotherapy of recurrent glioblastoma multiforme by intracerebral perfusion of interleukin-2 and LAK cells.
Blancher A; Roubinet F; Grancher AS; Tremoulet M; Bonaté A; Delisle MB; Calot JP; Pourreau C; Franks C; Ducos J
Eur Cytokine Netw; 1993; 4(5):331-41. PubMed ID: 8117934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
